Carnosine

Generic Name
Carnosine
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C9H14N4O3
CAS Number
305-84-0
Unique Ingredient Identifier
8HO6PVN24W
Background

Carnosine has been investigated for the treatment of Gulf War Illness.

Associated Conditions
-
Associated Therapies
-

Effects of Carnosine In Patients With Peripheral Arterial Disease Patients

Phase 1
Not yet recruiting
Conditions
Interventions
First Posted Date
2024-06-28
Last Posted Date
2024-07-24
Lead Sponsor
Shahid Baba
Target Recruit Count
120
Registration Number
NCT06480760
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Louisville School of Medicine, Department of Medicine, Division of Environmental Medicine, Louisville, Kentucky, United States

Carnosine for Peripheral Arterial Disease

Phase 2
Completed
Conditions
Interventions
First Posted Date
2021-05-03
Last Posted Date
2022-08-04
Lead Sponsor
University of Louisville
Target Recruit Count
10
Registration Number
NCT04870229
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Louisville, Louisville, Kentucky, United States

Carnosine for Peripheral Vascular Disease

First Posted Date
2019-02-18
Last Posted Date
2020-12-29
Lead Sponsor
Monash University
Target Recruit Count
104
Registration Number
NCT03844113
Locations
๐Ÿ‡ฆ๐Ÿ‡บ

Monash Centre for Health Research and Implementation, Melbourne, Victoria, Australia

L-carnosine Prophylactic Effect on Oxaliplatin Induced Peripheral Neuropathy in GIT Cancer Patients

Phase 1
Completed
Conditions
Interventions
First Posted Date
2016-06-22
Last Posted Date
2017-04-24
Lead Sponsor
Cairo University
Target Recruit Count
65
Registration Number
NCT02808624
Locations
๐Ÿ‡ช๐Ÿ‡ฌ

Cairo University, Cairo, Kasr el Aini, Egypt

Carnosine and Cognitive Training in Schizophrenia

First Posted Date
2016-02-19
Last Posted Date
2022-08-23
Lead Sponsor
Abraham Reichenberg
Target Recruit Count
60
Registration Number
NCT02686697
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Icahn School of Medicine at Mount Sinai, New York, New York, United States

Treatment Study of Carnosine Versus Placebo in Gulf War Illness (GWI)

Phase 2
Completed
Conditions
Interventions
First Posted Date
2008-12-18
Last Posted Date
2019-06-28
Lead Sponsor
Georgetown University
Target Recruit Count
33
Registration Number
NCT00810368
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Georgetown University, Washington, District of Columbia, United States

L-Carnosine for Bipolar I Disorder

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2005-09-15
Last Posted Date
2016-01-11
Lead Sponsor
University of Pittsburgh
Target Recruit Count
47
Registration Number
NCT00177463
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Mayview State Hospital, Bridgeville, Pennsylvania, United States

๐Ÿ‡บ๐Ÿ‡ธ

Mon-Yough Community Services, Inc., McKeesport, Pennsylvania, United States

๐Ÿ‡บ๐Ÿ‡ธ

Western Psychiatric Institute and Clinic, Pittsburgh, Pennsylvania, United States

ยฉ Copyright 2024. All Rights Reserved by MedPath